Zynex, Inc. focuses on non-opioid pain management and patient monitoring, with a recent FDA approval and a promising product pipeline. Analyst firms remain positive on the company's prospects, and ...
Zynex missed on second-quarter revenue and earnings, and guided down. However, some of the near-term weakness was by design, as the company is cutting costs. The stock looks very cheap if the company ...
Products sold in the past by Zynex for pain management have failed to penetrate the market. Zynex's new products are radically different from their predecessors: more specific and innovative. The new ...
* Depreciation does not include amounts related to units on lease to third parties which are depreciated and included in cost of goods sold. ** Severance of former corporate employees which were fully ...
Zynex (NASDAQ:ZYXI) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Zynex to report an earnings ...
LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zynex, Inc. (“Zynex” or “the Company”) (NASDAQ:ZYXI) investors that the firm has initiated an investigation into possible ...
The lawsuit contends that Zynex engaged in a scheme to inflate its reported revenue by routinely sending patients more products, including electrodes, than were medically necessary. This practice, the ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Zynex ( (ZYXI)) has issued an ...
TipRanks on MSN
Zynex CCO Resigns Amid Separation Negotiations
An announcement from Zynex ( ($ZYXI) ) is now available. Zynex, Inc. announced that Anna Lucsok resigned as Chief Commercial Officer, effective ...
ENGLEWOOD, Colo., Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback